Marco L Davila Selected Research

Marco L Davila Research Topics

Disease

31	Neoplasms (Cancer) 12/2023 - 11/2011
12	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 01/2020
10	Cytokine Release Syndrome 01/2023 - 02/2014
10	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 11/2011
8	Hematologic Neoplasms (Hematological Malignancy) 04/2023 - 04/2014
7	Lymphoma (Lymphomas) 01/2023 - 02/2017
4	Leukemia 01/2020 - 04/2014
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2018 - 11/2011
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 01/2021
3	Cytopenia 01/2023 - 01/2021
3	Infections 12/2022 - 12/2018
3	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2022 - 01/2020
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2024 - 12/2019
2	Inflammation (Inflammations) 04/2023 - 01/2023
2	Multiple Myeloma 03/2023 - 12/2022
2	cell-associated neurotoxicity 01/2021 - 12/2020
2	Philadelphia Chromosome 01/2018 - 02/2014
2	Residual Neoplasm 03/2013 - 11/2011
1	Cardiotoxicity 04/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 03/2023
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2023
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023
1	Bronchiolitis Obliterans Syndrome 11/2022
1	Bites and Stings (Sting) 03/2022
1	Pleural Effusion (Pleural Effusions) 01/2021
1	Disease Progression 01/2021
1	Abdominal Pain (Pain, Abdominal) 12/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2016
1	B-Cell Leukemia (Leukemia, B Cell) 11/2011
1	Lymphadenopathy 11/2011

Drug/Important Bio-Agent (IBA)

31	Chimeric Antigen ReceptorsIBA 01/2024 - 04/2013
9	axicabtagene ciloleucelIBA 01/2023 - 12/2019
5	CytokinesIBA 04/2023 - 03/2013
2	Interleukin-6 (Interleukin 6)IBA 04/2023 - 01/2021
2	LigandsIBA 03/2023 - 01/2021
2	tocilizumab (atlizumab)FDA Link 01/2023 - 01/2021
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2021
2	tisagenlecleucelIBA 01/2023 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022 - 02/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 02/2014
2	AntigensIBA 03/2015 - 11/2011
2	CD19 AntigensIBA 04/2014 - 02/2014
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	CreatinineIBA 04/2023
1	Biomarkers (Surrogate Marker)IBA 04/2023
1	Troponin IIBA 04/2023
1	Interleukin-15 (Interleukin 15)IBA 04/2023
1	NK Cell Lectin-Like Receptor Subfamily KIBA 03/2023
1	Zoledronic Acid (Zometa)FDA Link 01/2023
1	Peptidoglycan (Murein)IBA 01/2023
1	CD83 AntigenIBA 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	idecabtagene vicleucelIBA 12/2022
1	ofatumumab FDA Link 11/2022
1	GlucocorticoidsIBA 11/2022
1	Prednisone (Sone)FDA LinkGeneric 11/2022
1	2-toluenesulfonamide (OTS)IBA 03/2022
1	Death Domain ReceptorsIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022
1	Indomethacin (Indometacin)FDA LinkGeneric 01/2022
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2022
1	Ferritins (Ferritin)IBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2021
1	InterferonsIBA 01/2021
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	SteroidsIBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Calcineurin InhibitorsIBA 01/2020
1	CatecholaminesIBA 12/2018
1	alpha-Methyltyrosine (Metirosine)FDA Link 12/2018
1	AntibodiesIBA 12/2018
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 02/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2011

Therapy/Procedure

32	Therapeutics 01/2024 - 01/2013
10	Drug Therapy (Chemotherapy) 01/2022 - 11/2011
9	Immunotherapy 04/2023 - 03/2015
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 03/2015
3	Hematopoietic Stem Cell Transplantation 01/2021 - 03/2013
1	Length of Stay 01/2021
1	Salvage Therapy 01/2021
1	Cell Transplantation 01/2020
1	Radiotherapy 12/2019
1	Drug Tapering 12/2019
1	Traction 11/2015